Testis-specific insulin homolog polypeptides
US6183991A · kind A · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 1999 |
| Grant date | Feb 6, 2001 |
| Priority date | — |
| Expiry date | May 18, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides testis-specific insulin homolog polypeptides and polynucleotides encoding the polypeptides, as well as related compositions and methods are disclosed. The polypeptides and polynucleotides may be used within methods for enhancing viability of cryopreserved sperm, for enhancing sperm motility, to enhance fertilization in methods of assisted reproduction, as contraceptives and other related uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.